Hi Kay0987
Yes, the Anastrozole gave me most of the usual debilitating SEs which were increasing in severity as time went on. These (such as the sleep disturbance, painful joints - including useless hands eventually, hair loss, low mood or irritability, hot flushes, dry skin, brittle nails, chronic fatigue which leaves one unable to engage with life properly … whilst also trying to get on top of lymphoedema and Diabetes Type 2), and everything else associated with oestrogen starvation (which many people may escape, although I don’t understand how because no doctor has ever afforded me the time to explain much) are not to be confused, however, with my deeper dread of the following:
(NB I did read the Cancer Research UK ‘advice and information on Letrozole’ - designed to be reassuring. Thank you, but it’s not a scientific trial report as such, with backed-up statistics illustrating the degrees of severity across the whole sample group.)
I hadn’t wanted to make what I’d read for myself to be too confronting on this forum but the point I have been trying to make all along is that these were not the only reason for stopping hormone therapy. It was when I looked further into the rare or very rare SEs that I decided I did not want to risk losing my sight, getting uterine cancer, neutropenia (compromised immune system), atypical femoral fractures due to the interference of bisphosphonates with normal bone metabolism (I was beginning to get aching in my thighs - a warning sign) or more commonly, high cholesterol (already raised, and in turn carries risk of stroke / heart attack).
I was offered Tamoxifen instead but its potential damage seemed even worse, including thromboembolism. Even its common / very common SEs lists cerebral ischemia which could result in death, retinopathy (I am already at risk due to Diabetes Type 2), hepatic disorders, benign or malignant tumours… and that’s before moving into the uncommon and rare ones.
So … several risks of death, of which recurring breast cancer is but one.
I am not scaremongering - the information is readily available (on the NICE website, for example) to anyone curious/anxious enough to look for it.
Balancing the chance of any or all of these assaults on the body against a 2% reduction of
‘bc recurrence risk’ seemed like a no-brainer to me, personally.
You mention Stage 4, ie metastatic, cancer. Correct me if I’m wrong, but isn’t metastasis a different issue from trying to prevent a new primary breast cancer from reoccurring using oestrogen suppression? This is the sort of analysis I was unable to get three oncologists to engage in.
Instinct is what compelled me to quickly refer myself regarding a small lump that felt just like all the other cysts before. I ‘knew’ this was going to be the one (and in the course of investigations, another tumour of a different, more serious type, which remained hidden on subsequent mammos and ultrasound, was eventually found in the other breast).
Instinct saved me that time. I’m sticking with it.
I think earlier diagnosis and breast self awareness has to take credit for more lives actually being saved, along with its resultant surgery, radiotherapy and chemo (about which knowledge and methods are improving all the time). Aren’t AIs aimed more at protection and prevention, which you could argue results in less people developing another cancer? I suppose you could class that as ‘saved’ in a way? But equally (or most likely, statistically), they would not have got another breast cancer without the drugs anyway. That’s what I’m hanging my hopes on.
Ultimately, if someone suffers no SEs, or only to a degree that they can manage to live with, and if they do not fear any of the other very serious potential conditions which endocrine therapy can cause, then of course they should keep taking the tablets. They are just not a riskless guarantee.